User Interface Streamlines Proton Therapy Steps
By MedImaging International staff writers Posted on 24 May 2012 |
A new interface for a proton therapy system streamlines the steps for positioning, imaging, and treating patients with image-guided intensity-modulated proton therapy (IMPT).
Varian Medical Systems (Palo Alto, CA, USA) presented a new user interface for the company’s ProBeam proton therapy system at the upcoming annual meeting of the Particle Therapy Co-Operative Group (PTCOG 51) held in Seoul (Korea), May 14-19, 2012.
The new user interface for Varian’s ProBeam system is based on technology that was developed for the TrueBeam system for radiotherapy and radiosurgery. This includes a user-friendly treatment console that incorporates all controls for imaging, treatment, and motion management in one graphic, easy-to-use interface. “We have capitalized on Varian’s long experience designing interfaces for efficient clinical use,” said Moataz Karmalawy, head of Varian’s particle therapy group. “Clinicians who are already conversant with the TrueBeam system should have an easy time learning to operate a ProBeam system, and moving back and forth between the two.”
IMPT involves shaping the dose so that it matches the shape of the targeted tumor in three dimensions. Varian’s ProBeam system utilizes Dynamic Peak scanning, which optimizes the dose applied to every point within the area being treated. This makes it especially useful for targeting tumors with complex shapes, or tumors that wrap around critical structures like the spinal cord.
Another feature of the system, Dynamic Peak imaging, enables the use of imaging to further enhance the accuracy of tumor targeting. “Varian’s ProBeam system has been developed as a complete solution that is tightly integrated with the Aria oncology information system and Eclipse treatment planning,” said Mr. Karmalawy. “This enables an efficient and integrated workflow for planning and delivering high-quality image-guided IMPT treatments.”
Varian has equipped the Rinecker Proton Therapy Center (RPTC) in Munich (Germany), site of the world’s first clinical IMPT treatments. Construction work continues at the Scripps Proton Therapy Center (San Diego, CA, USA), which is being equipped with Varian hardware and software. The Scripps Center expects to begin treating patients in the spring of 2013. Varian has booked proton therapy technology orders for centers in Saudi Arabia and Russia, and has been named the preferred supplier for several other proton therapy ventures globally. The company’s Eclipse treatment planning system is being used to plan proton therapy treatments at several currently operating centers, and will be installed in over half of the new centers that are currently being built worldwide.
Related Links:
Varian Medical Systems
Varian Medical Systems (Palo Alto, CA, USA) presented a new user interface for the company’s ProBeam proton therapy system at the upcoming annual meeting of the Particle Therapy Co-Operative Group (PTCOG 51) held in Seoul (Korea), May 14-19, 2012.
The new user interface for Varian’s ProBeam system is based on technology that was developed for the TrueBeam system for radiotherapy and radiosurgery. This includes a user-friendly treatment console that incorporates all controls for imaging, treatment, and motion management in one graphic, easy-to-use interface. “We have capitalized on Varian’s long experience designing interfaces for efficient clinical use,” said Moataz Karmalawy, head of Varian’s particle therapy group. “Clinicians who are already conversant with the TrueBeam system should have an easy time learning to operate a ProBeam system, and moving back and forth between the two.”
IMPT involves shaping the dose so that it matches the shape of the targeted tumor in three dimensions. Varian’s ProBeam system utilizes Dynamic Peak scanning, which optimizes the dose applied to every point within the area being treated. This makes it especially useful for targeting tumors with complex shapes, or tumors that wrap around critical structures like the spinal cord.
Another feature of the system, Dynamic Peak imaging, enables the use of imaging to further enhance the accuracy of tumor targeting. “Varian’s ProBeam system has been developed as a complete solution that is tightly integrated with the Aria oncology information system and Eclipse treatment planning,” said Mr. Karmalawy. “This enables an efficient and integrated workflow for planning and delivering high-quality image-guided IMPT treatments.”
Varian has equipped the Rinecker Proton Therapy Center (RPTC) in Munich (Germany), site of the world’s first clinical IMPT treatments. Construction work continues at the Scripps Proton Therapy Center (San Diego, CA, USA), which is being equipped with Varian hardware and software. The Scripps Center expects to begin treating patients in the spring of 2013. Varian has booked proton therapy technology orders for centers in Saudi Arabia and Russia, and has been named the preferred supplier for several other proton therapy ventures globally. The company’s Eclipse treatment planning system is being used to plan proton therapy treatments at several currently operating centers, and will be installed in over half of the new centers that are currently being built worldwide.
Related Links:
Varian Medical Systems
Latest Nuclear Medicine News
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
- New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more